Healthcare & Life Sciences
INFEX Therapeutics
United Kingdominfextx.com/
INFEX Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About INFEX Therapeutics
Based in the United Kingdom, INFEX Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
INFEX Therapeutics acquires, develops, and licenses innovative anti-infective drugs to treat pandemic and drug-resistant infections, advancing clinical programs including RESP-X (INFEX702) into Phase IIa trials.
Explore INFEX Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.